Venator Capital Management Ltd. Orgenesis Inc. Transaction History

Venator Capital Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$2.6 - $4.66 $398,442 - $714,131	-153,247 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.18 - $4.85 $634,327 - $736,002	-151,753 Reduced 49.76%	153,247 $685,000
Q2 2019 Aug 14, 2019	BUY	$3.86 - $5.2 $459,814 - $619,439	119,123 Added 64.09%	305,000 $1.36 Million
Q1 2019 May 15, 2019	BUY	$4.28 - $5.6 $795,553 - $1.04 Million	185,877 New	185,877 $991,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Venator Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Venator Capital Management Ltd. with notifications on news.